[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

about

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

Item

http://www.wikidata.org/entity/Q53322716

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@en

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@nl

type

Item

label

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@en

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@nl

prefLabel

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@en

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy].

@nl

P1476

[Vertebral metastases of urogenital carcinomas: Diagnosis and conservative therapy]

@en

P2093

B Keck

http://www.w3.org/2001/XMLSchema#string

B Wullich

http://www.w3.org/2001/XMLSchema#string

M Hammon

http://www.w3.org/2001/XMLSchema#string

M Uder

http://www.w3.org/2001/XMLSchema#string

P J Goebell

http://www.w3.org/2001/XMLSchema#string

R H Richter

http://www.w3.org/2001/XMLSchema#string

P2860

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

Alpha emitter radium-223 and survival in metastatic prostate cancer

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

Bone imaging in metastatic breast cancer.

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.

Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

Prostate-specific membrane antigen-based imaging.

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

P304

226-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00120-015-3977-Y

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Johannes Huber

Frank Kunath

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26450096

http://www.w3.org/2001/XMLSchema#string